Wall Street Brunch: Here Comes Nvidia
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Kiniksa Pharmaceuticals (KNSA) dividend
When will Kiniksa Pharmaceuticals pay the next dividends?
The date of payment of the next dividends from the Kiniksa Pharmaceuticals is scheduled for N/A.
If you see an old date, it means that the company has not yet approved a new dividend payout date. As soon as they do, we will update the information immediately. Bookmark our site to stay informed.
Kiniksa Pharmaceuticals dividend per share:
Dividends are paid at $ None per share.
Kiniksa Pharmaceuticals dividend history:
Previous date of dividend payment: N/A.
Splitting upKiniksa Pharmaceuticals shares:
No information concerning Kiniksa Pharmaceuticals splitting shares.
Last Split Factor: N/A
Kiniksa Pharmaceuticals stock forecast.
What will happen to Kiniksa Pharmaceuticals stock? Kiniksa Pharmaceuticals shares will rise or fall. Visit the prediction section of our website to get an answer to this question.
Sell or Buy Kiniksa Pharmaceuticals (KNSA) stocks? Analytic Experts Forecasting...
Kiniksa Pharmaceuticals stock chart in real time
A real-time chart of the Kiniksa Pharmaceuticals stock price is shown below. By default, the chart is set to the daily timeframe, but you can change it to the one that interests you. You can also use indicators on the chart.
Kiniksa Pharmaceuticals information and performance
Kiniksa Pharmaceuticals Address
CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON, BM
Market Capitalization: 1 402 486 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -28 331 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: 152.08
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
DPS: None
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: None
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: 0.13
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: 5.5
Quarterly Revenue Growth YOY: 0.652
Trailing PE: 152.08
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 3.799
Enterprise Value (EV) /Revenue
EV To EBITDA: -44.93
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 40305400
Number of issued ordinary shares
Shares Float:
Number of freely tradable shares
Shares Short Prior Month:
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio:
Percent Insiders:
Percent Institutions: